Kodiak Sciences Inc KOD.OQ KOD.O is expected to show no change in quarterly revenue when it reports results on November 15 (estimated) for the period ending September 30 2024
LSEG's mean analyst estimate for Kodiak Sciences Inc is for a loss of 90 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and 3 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Kodiak Sciences Inc is 3.00, below its last closing price of $5.08.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2024 | -0.87 | -0.87 | -0.86 | Beat | 1.4 |
Jan. 1 2024 | -1.06 | -1.07 | -0.82 | Beat | 23.2 |
Dec. 31 2023 | -0.68 | -0.77 | -1.13 | Missed | -46.1 |
Jan. 1 0001 | -1.31 | -1.21 | -0.95 | Beat | 21.3 |
Jun. 30 2023 | -1.00 | -1.14 | -1.53 | Missed | -34.1 |
Mar. 31 2023 | -1.21 | -1.33 | -1.35 | Missed | -1.8 |
Dec. 31 2022 | -1.53 | -1.35 | Beat | 11.5 | |
Sep. 30 2022 | -1.77 | -1.77 | -1.47 | Beat | 16.9 |
This summary was machine generated November 13 at 15:44 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments